Skip to main content

Advertisement

Log in

Xinfeng Capsule (新风胶囊) for the treatment of rheumatoid arthritis patients with decreased pulmonary function — A randomized controlled clinical trial

  • Original Article
  • Published:
Chinese Journal of Integrative Medicine Aims and scope Submit manuscript

Abstract

Objective

To determine the effectiveness and safety of Xinfeng Capsules (新风胶囊, XFC) for the treatment of rheumatoid arthritis (RA) patients with decreased pulmonary function.

Methods

This was a randomized controlled clinical trial of 80 RA patients. Participants were assigned to the trial group (40 cases) and the control group (40 cases) by block randomization. The trial group was treated with XFC, three pills each time three times daily for 2 months. The control group was treated with tripterygium glycoside (TPT), two pills each time three times daily for 2 months. Both groups were followed up after 2 months. The clinical effects, changes in joint and pulmonary function, and quality of life before and after treatment were observed; safety indices were also evaluated.

Results

Pain, swelling, tenderness, and duration of morning stiffness of joints were obviously decreased after treatment in both the trial and the control groups compared with baseline (P<0.01). Compared with before treatment, hand grip strength increased significantly after treatment in the trial group (P=0.0000); pulmonary function parameters such as forced expiratory volume in the first second of expiration/forced vital capacity (FEV1/FVC), 50% of the expiratory flow of forced vital capacity (FEF50), carbon monoxide diffusing capacity (DLco) were increased (P<0.01 or P<0.05); measures of quality of life such as role-physical, body pain, vitality and mental health were also improved after treatment in the trial group (all P<0.05). Joint swelling in the trial group decreased compared with the control group (P=0.0043), while hand grip strength was increased after treatment (P=0.0000). The increase in FEF50, DLco, and the dimensions of quality of life such as vitality and mental health were all significantly greater in the trial group than the control group (P<0.05 or P<0.01).

Conclusions

XFC not only relieved joint pain in RA patients, but also significantly improved the ventilation and diffusion function of the lungs. Therefore, XFC could improve the whole body function and enhance the quality of life of RA patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Takeuchi T. Achievement in therapy for rheumatoid arthritis without dysfunctional sequela. Clin Calcium 2012;22:167.

    PubMed  Google Scholar 

  2. Furukawa H, Oka S, Shimada K, Sugii S, Ohashi J, Matsui T, et al. Association of human leukocyte antigen with interstitial lung disease in rheumatoid arthritis: a protective role for shared epitope. PLoS One 2012;7:e33133.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  3. Uhm DC, Nam ES, Lee HY, Lee EB, Yoon YI, Chai GJ. Health-related quality of life in Korean patients with rheumatoid arthritis: association with pain, disease activity, disability in activities of daily living and depression. J Kor Acad Nurs 2012;42:434–442.

    Article  Google Scholar 

  4. Santi V, Legovi D, Sestan B, Jurdana H, Marinovi M. Measuring improvement following total hip and knee arthroplasty using the SF-36 Health Survey. Coll Antropol 2012;36:207–212.

    Google Scholar 

  5. Wu GL, Li TY, Fan YS, Yu GY. Therapeutic effect of Chinese herbal medicine for strengthening qi, nourishing yin, and removing stasis on serum osteopontin and quality of life of patients with primary Sjogren's syndrome. Chin J Integr Med 2011;17:710–714.

    Article  PubMed  Google Scholar 

  6. Cao YX, Liu J, Zhu Y. Effect of Xinfeng Capsule on the cardiac function in patients with rheumatoid arthritis. Chin J Integr Med 2011;17:738–743.

    Article  CAS  PubMed  Google Scholar 

  7. Liu J, Liu RL. The potential role of Chinese medicine in ameliorating extra-articular manifestations of rheumatoid arthritis. Chin J Integr Med 2011;17:735–737.

    Article  PubMed  Google Scholar 

  8. Liu J, Yu XF, Zong RK, Wang Y. Effects Xinfeng Capsule on patients of active rheumatoid arthritis with depression. J Tianjin Tradit Chin Med (Chin) 2008;25:274–276.

    Google Scholar 

  9. Liu J, Yu XF, Zong RK. Effects of Xinfeng Capsule on behaviors and myocardial ultrastructure in adjuvant arthritis rats. J Chin Integr Tradit West Med (Chin) 2008;28:606–610.

    Article  CAS  Google Scholar 

  10. Hakala M, Pöllänen R, Nieminen P. The ARA 1987 revised criteria select patients with clinical rheumatoid arthritis from a population based cohort of subjects with chronic rheumatic diseases registered for drug reimbursement. J Rheumatol 1993;20:1674–1678.

    CAS  PubMed  Google Scholar 

  11. Ministry of Health of the People's Republic of China. Clinical guideline of new drugs for traditional Chinese medicine (Trial). Beijing: China Medical Science Press; 1993:91–94.

  12. Bian ZX, Li YP, Moher D, Dangenais S, Liu L, Wu TX, et al. Improving the quality of randomized controlled trials in Chinese herbal medicine. Part I: clinical trial design and methodology. J Chin Integr Med 2006;4:120–129.

    Article  Google Scholar 

  13. Zheng XY. Clinical guideline of new drugs of traditional Chinese medicine. Beijing: Chinese Medicine Science and Technology Publishing House; 2002:64,115,118.

    Google Scholar 

  14. Prevoo ML, van't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:315–324.

    Article  Google Scholar 

  15. Ware JE, Snow KK, Kosinski M, SF-36 health survey manual and interpretation guide. Boston: Quality Metric Incorporated; 1993:203–205.

    Google Scholar 

  16. Liu CJ, Li NX, Ren XH, Li J, Zhang J, Sun D. Feasibility of using Short Form 36 in Chinese population. J West Chin Univ Med Sci (Chin) 2001;32:39–42.

    CAS  Google Scholar 

  17. Li J, Liu CJ, Li NX, He TW, Li BY. Scaling the SF-36 in a Chinese population. J West Chin Univ Med Sci (Chin) 2001;32:36–38, 47.

    CAS  Google Scholar 

  18. Chen GZ, Xu YX, Zhang JW, Liu SH, Guo ZY. Effect of acupoint catgut-embedding on the quality of life, reproductive endocrine and bone metabolism of postmenopausal women. Chin J Integr Med 2010;16:498–503.

    Article  PubMed  Google Scholar 

  19. Yang QY, Lu S, Sun HR. Clinical effect of Astragalus granule of different dosages on quality of life in patients with chronic heart failure. Chin J Integr Med 2011;17:146–149.

    Article  PubMed  Google Scholar 

  20. Li H, Liu LT, Zhao WM, Liu JG, Yao MJ, Han YX, et al. Effect of traditional and integrative regimens on quality of life and early renal impairment in elderly patients with isolated systolic hypertension. Chin J Integr Med 2010;16:216–221.

    Article  PubMed  Google Scholar 

  21. Basra MK, Hussain S. Application of the dermatology life quality index in clinical trials of biologics for psoriasis. Chin J Integr Med 2012;18:179–185.

    Article  PubMed  Google Scholar 

  22. Shen HH, Wang K, Li W, Ying YH, Gao GX, Li XB, et al. Astragalus Membranaceus prevents airway hyperreactivity in mice related to Th2 response inhibition. J Ethnopharmacol 2008;116:363–369.

    Article  PubMed  Google Scholar 

  23. Wei H, Sun R, Xiao W, Feng J, Zhen C, Xu X, Tian Z. Traditional Chinese medicine Astragalus reverses predominance of Th2 cytokines and their up-stream transcript factors in lung cancer patients. Oncol Rep 2003;10:1507–1512.

    PubMed  Google Scholar 

  24. Dong JC, Zhao FD, Xie JY. Effects of milkvetch root on neuro-endocrino-immune network in asthma model rat. Chin J Integr Tradit West Integr Med (Chin) 2007;27:619–622.

    Google Scholar 

  25. Yao HT, Lin JH, Chiang MT, Chiang W, Luo MN, Lii CK. Suppressive effect of the ethanolic extract of adlay bran on cytochrome P-450 enzymes in rat liver and lungs. J Agric Food Chem 2011;59:4306–4314.

    Article  CAS  PubMed  Google Scholar 

  26. Hoyle GW, Hoyle CI, Chen J, Chang W, Williams RW, Rando RJ. Identification of triptolide, a natural diterpenoid compound, as an inhibitor of lung inflammation. Am J Physiol Lung Cell Mol Physiol 2010;298:L830–L836.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  27. Chen M, Lv Z, Jiang S. The effects of triptolide on airway remodelling and transforming growth factor-ß1/ Smad signalling pathway in ovalbumin-sensitized mice. Immunology 2011; 32:376–384.

    Article  Google Scholar 

  28. Zhao HM, Zuo ZQ, Cheng SM. Effects of scorpion and centipede on IL-2, IL-4, and IL-10 in the small intestinal mucosa and joint injury of rats with collagen induced arthritis. Chin J Integr Tradit West Integr Med (Chin) 2012;32:80–83.

    Google Scholar 

  29. Ai Q, Zhang JH, Tian G, Yang Y, Li DY, Gao M. Effect of Astragalus implant on actions of mice with chronic unpredictable mild stress depression. J Dalian Med Univ (Chin) 2010;32:405–407.

    Google Scholar 

  30. Ding YP, Ma LM, Li YP. The effect of Astragalus injection on the behavior and SOD activity and MAD content of hippocampus in chronic stress depression rats. J Northwest Normal Univ (Chin) 2011;47(6):75–79.

    Google Scholar 

  31. Lu YL, Wang ML, Yan Y. Coix comprehensive development and utilization. Food Nutri China (Chin) 2013;19:64–66.

    Google Scholar 

  32. An XD, Lin Z, May BH, Lin L, Xu YJ, Xue CL. Oral Chinese herbal medicine for improvement of quality of life in patients with stable chronic obstructive pulmonary disease: a systematic review. J Altern Complement Med 2012;18:731–743.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jian Liu  (刘 健).

Additional information

Supported by the Natural Science Foundation of China (No. 81403388, 81173211); Anhui Province Natural Science Fund Project of China (No. 1508085QH159); Key Discipline of Chinese Bi Disease Science Projects, State Administration of Traditional Chinese Medicine (No. [2009]30); Anhui College of Traditional Chinese Medicine Science and Technology Innovation Team Project (No. 2010TD005); and the Fund Supported by Anhui University of Chinese Medicine University (No. 2014qn025)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wan, L., Liu, J., Huang, Cb. et al. Xinfeng Capsule (新风胶囊) for the treatment of rheumatoid arthritis patients with decreased pulmonary function — A randomized controlled clinical trial. Chin. J. Integr. Med. 22, 168–176 (2016). https://doi.org/10.1007/s11655-015-2093-6

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11655-015-2093-6

Keywords

Navigation